|
1
|
Baltazar T, Dinis-Oliveira RJ, Duarte JA,
de Lourdes Bastos M and Carvalho F: Paraquat research: Do recent
advances in limiting its toxicity make its use safer? Br J
Pharmacol. 168:44–45. 2013. View Article : Google Scholar :
|
|
2
|
Moon JM, Chun BJ and Cho YS: The
characteristics of emergency department presentations related to
acute herbicide or insecticide poisoning in South Korea between
2011-2014. J Toxicol Environ Health A. 79:466–476. 2016. View Article : Google Scholar
|
|
3
|
Sun B and Chen YG: Advances in the
mechanism of paraquat-induced pulmonary injury. Eur Rev Med
Pharmacol Sci. 20:1597–1602. 2016.PubMed/NCBI
|
|
4
|
Li G, Yuzhen L, Yi C, Xiaoxiang C, Wei Z,
Changqing Z and Shuang Y: DNaseI protects against paraquat-induced
acute lung injury and pulmonary fibrosis mediated by mitochondrial
DNA. Biomed Res Int. 2015:3869522015.PubMed/NCBI
|
|
5
|
Liu ZN, Zhao M, Zheng Q, Zhao HY, Hou WJ
and Bai SL: Inhibitory effects of rosiglitazone on paraquat-induced
acute lung injury in rats. Acta Pharmacol Sin. 34:1317–1324. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Z, Sun M, Wang Y, Zhang L, Zhao H and
Zhao M: Silymarin attenuated paraquat-induced cytotoxicity in
macrophage by regulating Trx/TXNIP complex, inhibiting NLRP3
inflammasome activation and apoptosis. Toxicol In Vitro.
46:265–272. 2018. View Article : Google Scholar
|
|
7
|
Toygar M, Aydin I, Agilli M, Aydin FN,
Oztosun M, Gul H, Macit E, Karslioglu Y, Topal T, Uysal B and Honca
M: The relation between oxidative stress, inflammation, and
neopterin in the paraquat-induced lung toxicity. Hum Exp Toxicol.
34:198–1204. 2015. View Article : Google Scholar
|
|
8
|
Chen T, Wang R, Jiang W, Wang H, Xu A, Lu
G, Ren Y, Xu Y, Song Y, Yong S, et al: Protective effect of
astragaloside IV against paraquat-induced lung injury in mice by
suppressing rho signaling. Inflammation. 39:483–492. 2016.
View Article : Google Scholar
|
|
9
|
Levy BD and Serhan CN: Resolution of acute
inflammation in the lung. Annu Rev Physiol. 76:467–492. 2014.
View Article : Google Scholar
|
|
10
|
Shimizu S, Ogawa T, Seno S, Kouzaki H and
Shimizu T: Pro-Resolution mediator lipoxin A4 and its receptor in
upper airway inflammation. Ann Otol Rhinol Laryngol. 122:683–689.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Romano M, Cianci E, Simiele F and
Recchiuti A: Lipoxins and aspirin-triggered lipoxins in resolution
of inflammation. Eur J Pharmacol. 5:49–63. 2015. View Article : Google Scholar
|
|
12
|
Zhang L, Wu P, Jin Sw, Yuan P, Wan Jy,
Zhou Xy, Xiong W, Fang F and Ye Dy: Lipoxin A4 negatively regulates
lipopolysaccharide-induced differentiation of RAW264.7 murine
macrophages into dendritic-like cells. Chin Med J (Engl).
5:981–987. 2007. View Article : Google Scholar
|
|
13
|
Martini AC, Forner S, Bento AF and Rae GA:
Neuroprotective effects of lipoxin A4 in central nervous system
pathologies. Biomed Res Int. 2014:3162042014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu L, Li HH, Wu Q, Miao S, Liu ZJ, Wu P
and Ye DY: Lipoxin A4 activates Nrf2 pathway and ameliorates cell
damage in cultured cortical astrocytes exposed to oxygen-glucose
deprivation/reperfusion insults. J Mol Neurosci Aug. 56:848–857.
2015. View Article : Google Scholar
|
|
15
|
Zong L, Li J, Chen X, Chen K, Li W, Li X,
Zhang L, Duan W, Lei J, Xu Q, et al: Lipoxin A4 attenuates cell
invasion by inhibiting ROS/ERK/MMP pathway in pancreatic cancer.
Oxid Med Cell Longev. 2016:68157272016. View Article : Google Scholar
|
|
16
|
Zhou XY, Wu P, Zhang L, Xiong W, Li YS,
Feng YM and Ye DY: Effects of lipoxin A(4) on lipopolysaccharide
induced proliferation and reactive oxygen species production in
RAW264.7 macrophages through modulation of G-CSF secretion. Inflamm
Res. 56:324–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zong H, Li X, Lin H, Hou C and Ma F:
Lipoxin A4 pretreatment mitigates skeletal muscle
ischemia-reperfusion injury in rats. Am J Transl Res. 9:1139–1150.
2017.PubMed/NCBI
|
|
18
|
Zhao Q, Shao L, Hu X, Wu G, Du J, Xia J
and Qiu H: Lipoxin a4 preconditioning and postconditioning protect
myocardial ischemia/reperfusion injury in rats. Mediators Inflamm.
2013:2313512013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen XQ, Wu SH, Zhou Y and Tang YR:
Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against
hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE
complex. PLoS One. 24:e671202013. View Article : Google Scholar
|
|
20
|
Liu ZN, Zhao H, Liu W, Li T, Wang Y and
Zhao M: NLRP3 inflammasome activation is essential for
paraquat-induced acute lung injury. Inflammation. 38:433–444. 2015.
View Article : Google Scholar
|
|
21
|
Wang Q, Lian QQ, Li R, Ying BY, He Q, Chen
F, Zheng X, Yang Y, Wu DR, Zheng SX, et al: Lipoxin A(4) activates
alveolar epithelial sodium channel, na, K-ATPase, and increases
alveolar fluid clearance. Am J Resp Cell Mol Biol. 48:610–618.
2013. View Article : Google Scholar
|
|
22
|
Qi W, Li H, Cai XH, Gu JQ, Meng J, Xie HQ,
Zhang JL, Chen J, Jin XG, Tang Q, et al: Lipoxin A(4) activates
alveolar epithelial sodium channel gamma via the
microRNA-21/PTEN/AKT pathway in lipopolysaccharide-induced
inflammatory lung injury. Lab Invest. 95:1258–1268. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mikawa K, Nishina K, Takao Y and Obara H:
ONO-1714, a nitric oxide synthase inhibitor, attenuates
endotoxin-induced acute lung injury in rabbits. Anesth Analg.
97:1751–1755. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen H, Wu N, Wang Y, Guo F, Chen L, Zhang
Z, Jia D and Zhao M: MyD88 gene knockout attenuates
paraquat-induced acute lung injury. Toxicol Lett. 5:41–46. 2017.
View Article : Google Scholar
|
|
25
|
Kayama H, Ramirez-Carrozzi VR, Yamamoto M,
Mizutani T, Kuwata H, Iba H, Matsumoto M, Honda K, Smale ST and
Takeda K: Class-Specific regulation of pro-inflammatory genes by
MyD88 pathways and IκBζ. J Biol Chem. 290:48152015. View Article : Google Scholar
|
|
26
|
Hazeki K, Nigorikawa K and Hazeki O: Role
of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull.
30:1617–1623. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Androulidaki A, Iliopoulos D, Arranz A,
Doxaki C, Schworer S, Zacharioudaki V, Margioris AN, Tsichlis PN
and Tsatsanis C: The kinase akt1 controls macrophage response to
lipopolysaccharide by regulating microRNAs. Immunity. 21:220–231.
2009. View Article : Google Scholar
|
|
28
|
Ruse M and Knaus UG: New players in
TLR-mediated innate immunity: PI3K and small rho GTPases. Immunol
Res. 34:33–48. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rose MS, Smith LL and Wyatt I: Evidence
for energy-dependent accumulation of paraquat into rat lung.
Nature. 22:314–315. 1974. View
Article : Google Scholar
|
|
30
|
Wang X, Jiao W, Lin M, Lu C, Liu C, Wang
Y, Ma D, Wang X, Yin P, Feng J, et al: Resolution of inflammation
in neuromyelitis optica spectrum disorders. Mult Scler Relat
Disord. 27:34–41. 2019. View Article : Google Scholar
|
|
31
|
Börgeson E, Johnson AM, Lee YS, Till A,
Syed GH, Ali-Shah ST, Guiry PJ, Dalli J, Colas RA, Serhan CN, et
al: Lipoxin A4 attenuates obesity-induced adipose inflammation and
associated liver and kidney disease. Cell Metab. 7:125–137. 2015.
View Article : Google Scholar
|
|
32
|
Liu L, Zhang P, Zhang Z, Hu Q, He J, Liu
H, Zhao J, Liang Y, He Z, Li X, et al: LXA4 ameliorates
cerebrovascular endothelial dysfunction by reducing acute
inflammation after subarachnoid hemorrhage in rats. Neuroscience.
1:105–114. 2019. View Article : Google Scholar
|
|
33
|
Lu H, Zhen J, Wu T, Peng A, Ye T, Wang T,
Yu X, Vaziri ND, Mohan C and Zhou XJ: Superoxide dismutase mimetic
drug tempol aggravates anti-GBM antibody-induced glomerulonephritis
in mice. Am J Physiol Renal Physiol. 299:F445–F452. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Liu Y, Peng X, Liu W, Zhao F, Feng
D, Han J, Huang Y, Luo S, Li L, et al: NMDA receptor antagonist
attenuates bleomycin-induced acute lung injury. PLoS One.
5:e01258732015. View Article : Google Scholar
|
|
35
|
Kovach MA and Standiford TJ: Toll like
receptors in diseases of the lung. Int Immunopharmacol.
11:1399–1406. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Oakes JL, O'Connor BP, Warg LA, Burton R,
Hock A, Loader J, Laflamme D, Jing J, Hui L, Schwartz DA and Yang
IV: Ozone enhances pulmonary innate immune response to a toll-like
receptor-2 agonist. Am J Respir Cell Mol Biol. 48:27–34. 2013.
View Article : Google Scholar :
|
|
37
|
Qin C, Zhang B, Zhang L, Zhang Z, Wang L,
Tang L, Li S, Yang Y, Yang F, Zhang P and Yang B: MyD88-Dependent
toll-like receptor 4 signal pathway in intervertebral disc
degeneration. Exp Ther Med. 12:611–618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu W, Shan LP, Dong XS and Liu Z:
Toll-Like receptor 4 implicated in acute lung injury induced by
paraquat poisoning in mice. Int J Clin Exp Med. 5:3392–3397.
2014.
|
|
39
|
Dong XS, Xu XY, Sun YQ, Wei-Liu, Jiang ZH
and Liu Z: Toll-Like receptor 4 is involved in myocardial damage
following paraquat poisoning in mice. Toxicology. 312:115–122.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hu R, Xu H, Jiang H, Zhang Y and Sun Y:
The role of TLR4 in the pathogenesis of indirect acute lung injury.
Front Biosci (Landmark Ed). 2013 Jun 1;18:1244–55. View Article : Google Scholar
|
|
41
|
Li TT, Ogino S and Qian ZR: Toll-Like
receptor signaling in colorectal cancer: Carcinogenesis to cancer
therapy. World J Gastroenterol. 1:17699–17708. 2014. View Article : Google Scholar
|
|
42
|
Lawrence T: The nuclear factor NF-kappaB
pathway in inflammation. Cold Spring Harb Perspect Biol.
1:a0016512009. View Article : Google Scholar
|
|
43
|
Liu P, Zhou YS, Qin YL, Li L, Liu Y, Xu B,
Huang K, Ji CC, Lin F, Wang YG, et al: Mechanism of action for
oligomeric proanthocyaniclins in pava qnat-induced acute lung
injury. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 20:818–822.
2017.In Chinese.
|
|
44
|
Hu X, Shen H, Wang Y and Zhao M: Liver X
receptor agonist TO901317 attenuates paraquat-induced acute lung
injury through inhibition of NF-κB and JNK/p38 MAPK signal
pathways. Biomed Res Int. 2017:46526952017. View Article : Google Scholar
|
|
45
|
Liu Mw, Su Mx, Zhang W, Wang Yq, Chen M,
Wang L and Qian Cy: Protective effect of Xuebijing injection on
paraquat-induced pulmonary injury via down-regulating the
expression of p38 MAPK in rats. BMC Complement Altern Med.
16:4982014. View Article : Google Scholar
|
|
46
|
Troutman TD, Hu W, Fulenchek S, Yamazaki
T, Kurosaki T, Bazan JF and Pasare C: Role for B-cell adapter for
PI3K (BCAP) as a signaling adapter linking Toll-like receptors
(TLRs) to serine/threonine kinases PI3K/Akt. Proc Natl Acad Sci
USA. 3:273–278. 2012. View Article : Google Scholar
|
|
47
|
Chu AJ: Antagonism by bioactive
polyphenols against inflammation: A systematic view. Inflamm
Allergy Drug Targets. 13:34–64. 2014. View Article : Google Scholar
|
|
48
|
Lo JY, Kamarudin MN, Hamdi OA, Awang K and
Kadir HA: Curcumenol isolated from curcuma zedoaria suppresses
akt-mediated NF-κB activation and p38 MAPK signaling pathway in
LPS-stimulated BV-2 microglial cells. Food Funct. 6:3550–3559.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Madrid LV, Mayo MW, Reuther JY and Baldwin
AS Jr: Akt stimulates the transactivation potential of the RelA/p65
Subunit of NF-kappa B through utilization of the Ikappa B kinase
and activation of the mitogen-activated protein kinase p38. J Biol
Chem. 1:18934–18940. 2001. View Article : Google Scholar
|
